Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Takemi Otsuki, Haruko Sakaguchi, Tamayo Hatayama, Ping Wu, Akiko Takata & Fuminori Hyodoh. (2003) Effects of All-trans Retinoic Acid (ATRA) on Human Myeloma Cells. Leukemia & Lymphoma 44:10, pages 1651-1656.
Read now
Read now
Articles from other publishers (27)
Muthulekha Swamydas, Elena V. Murphy, James J. Ignatz-Hoover, Ehsan Malek & James J. Driscoll. (2022) Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Alessandro Allegra, Alessandro Tonacci, Caterina Musolino, Giovanni Pioggia & Sebastiano Gangemi. (2021) Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia. Frontiers in Immunology 12.
Crossref
Crossref
Fatih M. Uckun. (2021) Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma. Cancers 13:9, pages 2018.
Crossref
Crossref
Joanna Bartosińska, Joanna Purkot, Agnieszka Karczmarczyk, Michał Chojnacki, Joanna Zaleska, Paulina Własiuk, Norbert Grząśko, Marta Morawska, Adam Walter-Croneck, Lidia Usnarska-Zubkiewicz, Patrycja Zielińska, Krzysztof Jamroziak, Małgorzata Kowal, Dorota Krasowska, Grażyna Chodorowska & Krzysztof Giannopoulos. (2021) Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma. Cells 10:2, pages 411.
Crossref
Crossref
Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Regina Wan Ju Wong, Jing-Yuan Chooi, Julia Sze Lynn Lim, Takaomi Sanda, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Yongxia Chen, Enfan Zhang, Zhen Cai, Peng Shen, Jian Ruan & Wee-Joo Chng. (2021) Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma. Blood Cancer Journal 11:2.
Crossref
Crossref
Simone A. Minnie, Rachel D. KunsKate H. GartlanPing ZhangAndrew N. WilkinsonLuke SamsonCamille GuillereyChristian EngwerdaKelli P. A. MacDonaldMark J. SmythKate A. MarkeySlavica Vuckovic & Geoffrey R. Hill. (2018) Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade. Blood 132:16, pages 1675-1688.
Crossref
Crossref
Xuanru Lin, Li Yang, Gang Wang, Fuming Zi, Haimeng Yan, Xing Guo, Jing Chen, Qingxiao Chen, Xi Huang, Yi Li, Enfan Zhang, Wenjun Wu, Yang Yang, Donghua He, Jingsong He & Zhen Cai. (2017) Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells. Oncotarget 8:54, pages 92841-92854.
Crossref
Crossref
Upasana Kulkarni, Christian M. Karsten, Thomas Kohler, Sven Hammerschmidt, Kurt Bommert, Benjamin Tiburzy, Lingzhang Meng, Lara Thieme, Andreas Recke, Ralf J. Ludwig, Karolin Pollok, Kathrin Kalies, Bjarne Bogen, Martin Boettcher, Thomas Kamradt, Anja E. Hauser, Christian Langer, Markus Huber-Lang, Fred D. Finkelman, Jörg Köhl, David M. Wong & Rudolf Armin Manz. (2016) IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration. Journal of Allergy and Clinical Immunology 137:5, pages 1487-1497.e6.
Crossref
Crossref
Camille Guillerey, Kyohei Nakamura, Slavica Vuckovic, Geoffrey R. Hill & Mark J. Smyth. (2016) Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies. Cellular and Molecular Life Sciences 73:8, pages 1569-1589.
Crossref
Crossref
Michal Rihacek, Julie Bienertova-Vasku, Dalibor Valik, Jaroslav Sterba, Katerina Pilatova & Lenka Zdrazilova-Dubska. (2015) B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Adriana Zingone, Weixin Wang, Meghan Corrigan-Cummins, S. Peter Wu, Ryan Plyler, Neha Korde, Mary Kwok, Elisabet E. Manasanch, Nishant Tageja, Manisha Bhutani, Marcia Mulquin, Diamond Zuchlinski, Mary Ann Yancey, Mark Roschewski, Yong Zhang, Aldo M. Roccaro, Irene M. Ghobrial, Katherine R. Calvo & Ola Landgren. (2014) Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease. Cytokine 69:2, pages 294-297.
Crossref
Crossref
Chelsea HopeSamuel J. OllarErika HeningerEllen HebronJeffrey L. JensenJaehyup KimIoanna MaroulakouShigeki MiyamotoCatherine Leith, David T. Yang, Natalie CallanderPeiman HemattiMarta Chesi, P. Leif Bergsagel & Fotis Asimakopoulos. (2014) TPL2 kinase regulates the inflammatory milieu of the myeloma niche. Blood 123:21, pages 3305-3315.
Crossref
Crossref
Benjamin Tiburzy, Upasana Kulkarni, Anja Erika Hauser, Melanie Abram & Rudolf Armin Manz. (2014) Plasma cells in immunopathology: concepts and therapeutic strategies. Seminars in Immunopathology 36:3, pages 277-288.
Crossref
Crossref
Brian A McCarthy, Liqun Yang, Jane Ding, Mingqiang Ren, William King, Mohammed ElSalanty, Ibrahim Zakhary, Mohamed Sharawy, Hongjuan Cui & Han-Fei Ding. (2012) NF-κB2 mutation targets survival, proliferation and differentiation pathways in the pathogenesis of plasma cell tumors. BMC Cancer 12:1.
Crossref
Crossref
Eva Kovacs. (2010) Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?. Leukemia Research 34:7, pages 912-916.
Crossref
Crossref
Li Zeng, Colleen O’Connor, Jiayou Zhang, Alan M. Kaplan & Donald A. Cohen. (2010) IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine 49:3, pages 294-302.
Crossref
Crossref
Philippe M. CampeauMoutih RafeiMarie-Noëlle BoivinYing Sun, Gregory A. Grabowski & Jacques Galipeau. (2009) Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome. Blood 114:15, pages 3181-3190.
Crossref
Crossref
Taishi Yamashita, Hideto Tamura, Chikako Satoh, Eiji Shinya, Hidemi Takahashi, Lieping Chen, Asaka Kondo, Takashi Tsuji, Kazuo Dan & Kiyoyuki Ogata. (2009) Functional B7.2 and B7-H2 Molecules on Myeloma Cells Are Associated with a Growth Advantage. Clinical Cancer Research 15:3, pages 770-777.
Crossref
Crossref
Barbara Zdzisińska, Agnieszka Bojarska-Junak, Anna Dmoszyńska & Martyna Kandefer-Szerszeń. (2008) Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells. Archivum Immunologiae et Therapiae Experimentalis 56:3.
Crossref
Crossref
Guy Pratt, Oliver Goodyear & Paul Moss. (2007) Immunodeficiency and immunotherapy in multiple myeloma. British Journal of Haematology 138:5, pages 563-579.
Crossref
Crossref
C. Pappa, S. Miyakis, G. Tsirakis, A. Sfiridaki, A. Alegakis, M. Kafousi, E.N. Stathopoulos & M.G. Alexandrakis. (2007) Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma. Cytokine 37:2, pages 171-175.
Crossref
Crossref
Dharminder Chauhan, Teru Hideshima & Kenneth C. Anderson. 2007. Cytokines in the Genesis and Treatment of Cancer. Cytokines in the Genesis and Treatment of Cancer
181
197
.
T. Otsuki, K. Yata, A. Takata-Tomokuni, F. Hyodoh, Y. Miura, H. Sakaguchi, T. Hatayama, S. Hatada, T. Tsujioka, Y. Sato, H. Murakami, Y. Sadahira & T. Sugihara. (2004) Expression of protein gene product 9·5 (PGP9·5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. British Journal of Haematology 127:3, pages 292-298.
Crossref
Crossref
Jerome E. Tanner. (2004) Nucleosomes activate NF‐κB in endothelial cells for induction of the proangiogenic cytokine IL‐8. International Journal of Cancer 112:1, pages 155-160.
Crossref
Crossref
Daniela Intini, Sonia Fabris, Tiziana Storlazzi, Takemi Otsuki, Gabriella Ciceri, Donata Verdelli, Luigia Lombardi, Mariano Rocchi & Antonino Neri. (2004)
Identification of a novel
IGH-MMSET
fusion transcript in a human myeloma cell line with the t(4;14)(p16·3;q32) chromosomal translocation
. British Journal of Haematology 126:3, pages 437-439.
Crossref
Crossref
Ron Kooijman & Astrid Coppens. (2004) Insulin-like growth factor-I stimulates IL-10 production in human T cells. Journal of Leukocyte Biology 76:4, pages 862-867.
Crossref
Crossref
Amit Panwalkar, Srdan Verstovsek & Francis J. Giles. (2004) Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer 100:4, pages 657-666.
Crossref
Crossref